Fidelity Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Fidelity Investments’s Portfolio REGN Stock Details REGN Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.75B	Sell	3,327,051 -4,271,533	-56%	-$2.24B	0.1%	161
2025 Q1	$4.82B	Sell	7,598,584 -600,995	-7%	-$381M	0.31%	39
2024 Q4	$5.84B	Sell	8,199,579 -2,163,122	-21%	-$1.54B	0.35%	32
2024 Q3	$10.9B	Sell	10,362,701 -286,773	-3%	-$301M	0.66%	18
2024 Q2	$11.2B	Sell	10,649,474 -144,598	-1%	-$152M	0.72%	16
2024 Q1	$10.4B	Buy	10,794,072 +476,657	+5%	+$459M	0.7%	18
2023 Q4	$9.06B	Buy	10,317,415 +476,523	+5%	+$419M	0.7%	16
2023 Q3	$8.1B	Buy	9,840,892 +669,517	+7%	+$551M	0.7%	15
2023 Q2	$6.59B	Sell	9,171,375 -268,721	-3%	-$193M	0.55%	22
2023 Q1	$7.76B	Sell	9,440,096 -1,656,895	-15%	-$1.36B	0.71%	15
2022 Q4	$8.01B	Buy	11,096,991 +287,245	+3%	+$207M	0.8%	15
2022 Q3	$7.45B	Buy	10,809,746 +633,547	+6%	+$436M	0.78%	14
2022 Q2	$6.02B	Buy	10,176,199 +193,175	+2%	+$114M	0.6%	20
2022 Q1	$6.97B	Sell	9,983,024 -79,943	-0.8%	-$55.8M	0.56%	21
2021 Q4	$6.35B	Sell	10,062,967 -1,004,984	-9%	-$635M	0.47%	28
2021 Q3	$6.7B	Buy	11,067,951 +157,257	+1%	+$95.2M	0.53%	25
2021 Q2	$6.09B	Sell	10,910,694 -25,295	-0.2%	-$14.1M	0.48%	29
2021 Q1	$5.17B	Sell	10,935,989 -545,585	-5%	-$258M	0.44%	33
2020 Q4	$5.55B	Sell	11,481,574 -1,236,734	-10%	-$597M	0.49%	25
2020 Q3	$7.12B	Buy	12,718,308 +254,828	+2%	+$143M	0.72%	17
2020 Q2	$7.77B	Buy	12,463,480 +3,999,170	+47%	+$2.49B	0.85%	16
2020 Q1	$4.13B	Buy	8,464,310 +5,238,483	+162%	+$2.56B	0.57%	21
2019 Q4	$1.21B	Buy	3,225,827 +492,339	+18%	+$185M	0.13%	146
2019 Q3	$758M	Sell	2,733,488 -462,308	-14%	-$128M	0.09%	214
2019 Q2	$1B	Sell	3,195,796 -1,227,209	-28%	-$384M	0.12%	169
2019 Q1	$1.82B	Sell	4,423,005 -924,371	-17%	-$380M	0.22%	82
2018 Q4	$2B	Buy	5,347,376 +330,875	+7%	+$124M	0.27%	66
2018 Q3	$2.03B	Buy	5,016,501 +728,104	+17%	+$294M	0.23%	78
2018 Q2	$1.48B	Sell	4,288,397 -895,620	-17%	-$309M	0.17%	105
2018 Q1	$1.79B	Sell	5,184,017 -445,322	-8%	-$153M	0.21%	96
2017 Q4	$2.12B	Sell	5,629,339 -1,362,383	-19%	-$512M	0.25%	70
2017 Q3	$3.13B	Sell	6,991,722 -48,162	-0.7%	-$21.5M	0.38%	39
2017 Q2	$3.46B	Buy	7,039,884 +416,192	+6%	+$204M	0.43%	34
2017 Q1	$2.57B	Sell	6,623,692 -1,200,634	-15%	-$465M	0.33%	55
2016 Q4	$2.87B	Sell	7,824,326 -1,310,024	-14%	-$481M	0.38%	41
2016 Q3	$3.67B	Sell	9,134,350 -282,486	-3%	-$114M	0.49%	32
2016 Q2	$3.29B	Buy	9,416,836 +795,283	+9%	+$278M	0.45%	41
2016 Q1	$3.11B	Buy	8,621,553 +2,398,461	+39%	+$865M	0.43%	40
2015 Q4	$3.38B	Buy	6,223,092 +613,071	+11%	+$333M	0.45%	36
2015 Q3	$2.61B	Sell	5,610,021 -322,126	-5%	-$150M	0.37%	45
2015 Q2	$3.03B	Sell	5,932,147 -78,523	-1%	-$40.1M	0.39%	37
2015 Q1	$2.71B	Sell	6,010,670 -676,422	-10%	-$305M	0.35%	47
2014 Q4	$2.74B	Buy	6,687,092 +719,663	+12%	+$295M	0.36%	44
2014 Q3	$2.15B	Buy	5,967,429 +686,906	+13%	+$248M	0.29%	66
2014 Q2	$1.49B	Sell	5,280,523 -462,512	-8%	-$131M	0.2%	106
2014 Q1	$1.72B	Sell	5,743,035 -1,500,348	-21%	-$451M	0.24%	83
2013 Q4	$1.99B	Sell	7,243,383 -1,710,715	-19%	-$471M	0.28%	66
2013 Q3	$2.8B	Sell	8,954,098 -1,344,261	-13%	-$421M	0.43%	39
2013 Q2	$2.32B	Buy	+10,298,359	New	+$2.32B	0.38%	47